Filing Details

Accession Number:
0001493152-21-012902
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-25 21:45:31
Reporting Period:
2021-05-25
Accepted Time:
2021-05-25 21:45:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1716166 Vivos Therapeutics Inc. VVOS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1425339 K. Bradford Amman 9137 S. Ridgeline Blvd, Suite 135
Highlands Ranch CO 80129
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-25 1,000 $5.29 2,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option $7.50 2026-03-12 100,000 100,000 Direct
Common Stock Stock Option $7.50 2024-11-18 16,667 16,667 Direct
Common Stock Stock Option $7.50 2023-10-22 83,334 83,334 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2026-03-12 100,000 100,000 Direct
2024-11-18 16,667 16,667 Direct
2023-10-22 83,334 83,334 Direct
Footnotes
  1. 100,000 stock options granted on March 12, 2021. One-fifth vested immediately and one-fifth vests annually on each anniversary date through March 12, 2025.
  2. 16,667 stock options granted on November 18, 2019. One-fifth vested immediately and one-fifth vests annually on each anniversary date through November 18, 2023.
  3. 83,334 stock options granted on November 18, 2019. One-fifth vested immediately and one-fifth vests annually on each anniversary date through October 22, 2022.